Skip to main content

Thiamine Injection Shortage

Last Updated: February 22, 2023
Status: Current

Reason for the Shortage
    • Eugia has thiamine injection available.
    • Fresenius Kabi has thiamine injection available.
    • Hikma has thiamine injection available.
    • Mylan Institutional (Viatris) has thiamine injection available.
    • Sagent has thiamine injection available.
Available Products
    • Thiamine injection, Eugia US, 100 mg/mL, 2 mL vial, 25 count, NDC 55150-0273-25
    • Thiamine injection, Fresenius Kabi, 100 mg/mL, 2 mL vial, 25 count, NDC 63323-0013-02
    • Thiamine injection, Hikma, 100 mg/mL, 2 mL vial, 25 count, NDC 00641-6228-25
    • Thiamine injection, Mylan Institutional (Viatris), 100 mg/mL, 2 mL vial, 25 count, NDC 67457-0196-02
    • Thiamine injection, Sagent, 100 mg/mL, 2 mL vial, 25 count, NDC 25021-0500-02

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated February 22, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 12, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.